BTAI BioXcel Therapeutics, Inc. - Common Stock
$0,84
Cena · Sie 18, 2026
Dane fundamentalne na dzień Sie 13, 2026
Zakres 52 tyg.
$1–$6
2% of range
Ocena Analityków
BUY
11 analysts
Cena Docelowa
$14
+1574% upside
P/E (TTM)
-0.2
ROE
68.8%
Marża Zysku Netto
-10887.4%
BTAI Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$0.84
Kapitalizacja Rynkowa
$23M
P/E (TTM)
-0.2
EPS (TTM)
$-5.73
Przychody (TTM)
$642.0K
Stopa dywidendy
—
ROE
68.8%
D/E Dług/Kapitał
-1.1
Zakres 52 tyg.
$1 – $6
BTAI Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Configure
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody i Zysk Netto
$642.0K
2022-12-31
→
2025-12-31
EPS
$-5.73
2020-12-31
→
2025-12-31
Wolny przepływ pieniężny
$-58M
2018-12-31
→
2025-12-31
Marże
-10887.4%
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
Wskaźnik
Trend 5-letni
BTAI
Mediana porównawcza
P/E (TTM)
-0.2
0.8
P/S (TTM)
35.3
6.2
P/B
-0.2
3.0
EV / EBITDA
-2.1
—
Price / FCF (Cena / FCF)
-0.4
—
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
Wskaźnik
Trend 5-letni
BTAI
Mediana porównawcza
Operating Margin (Marża Operacyjna)
-7860.0%
—
Net Profit Margin (Marża Zysku Netto)
-10887.4%
-1056.6%
ROA
-167.9%
-118.6%
ROE
68.8%
-139.5%
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
Wskaźnik
Trend 5-letni
BTAI
Mediana porównawcza
Debt / Equity (Dług / Kapitał Własny)
-1.1
—
Current Ratio (Wskaźnik bieżący)
0.8
2.1
Quick Ratio (Wskaźnik Szybkości)
0.5
—
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
Wskaźnik
Trend 5-letni
BTAI
Mediana porównawcza
Revenue YoY (Przychody R/R)
-71.7%
—
Revenue CAGR 3Y (Przychody CAGR 3L)
19.6%
—
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
Wskaźnik
Trend 5-letni
BTAI
Mediana porównawcza
BTAI Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
KUP
11 analityków
- Mocne kupno 2 18,2%
- Kup 7 63,6%
- Trzymaj 1 9,1%
- Sprzedaj 1 9,1%
- Mocna sprzedaż 0 0,0%
12-miesięczny cel cenowy
4 analityków · 2026-08-14
Mediana
$8.50
Średnia
$14.00
← Poniżej wszystkich celów
$0.84
Niski
$1.00
Wysoki
$38.00
Średni cel
$8.50
+916,6%
Średnia cel
$14.00
+1574,4%
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
1.2%
| Okres | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|
| 31 marca 2026 | $-0.54 | $-0.84 | 0.30% |
| 31 grudnia 2025 | $-0.58 | $-0.77 | 0.18% |
| 30 września 2025 | $-2.18 | $-1.20 | -0.98% |
| 30 czerwca 2025 | $-2.45 | $-1.89 | -0.56% |
| 31 marca 2025 | $-1.50 | $-6.79 | 5.3% |
| 31 grudnia 2024 | $-3.57 | $-6.55 | 3.0% |
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| BTAI | $36M | -0.3 | -71.7% | -10887.4% | 68.8% | — |
| ELUT | — | 0.8 | -15.0% | 434.2% | -753.4% | 53.7% |
| NXTC | $50M | -0.7 | — | — | -172.9% | — |
| QNCX | $187M | -2.0 | — | — | 700.5% | — |
| BYSI | — | — | — | — | 3.1% | — |
| LTRN | — | -1.9 | — | — | — | — |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat 16
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | $642.0K | $2M | $1M | $375.0K | |
| Cost of Revenue | $164.0K | $2M | $1M | $20.0K | |
| R&D Expense | $30M | $30M | $84M | $91M | |
| SG&A Expense | $20M | $34M | $83M | $69M | |
| Operating Expenses | $51M | $70M | $173M | $160M | |
| Operating Income | $-50M | $-67M | $-172M | $-160M | |
| Interest Expense | · | · | $13M | $8M | |
| Interest Income | $1M | $3M | $6M | $3M | |
| Other Non-op | $-4M | $20M | $394.0K | $-427.0K | |
| Income Tax | $0 | $0 | $0 | · | |
| Net Income | $-70M | $-60M | $-179M | $-166M | |
| EPS (Basic) | $-5.73 | $-23.51 | $-98.33 | $-5.92 | |
| EPS (Diluted) | $-5.73 | $-23.51 | $-98.33 | $-5.92 | |
| Shares (Basic) | 12,208,000 | 2,535,000 | 1,821,000 | 28,015,000 | |
| Shares (Diluted) | 12,208,000 | 2,535,000 | 1,821,000 | 28,015,000 | |
| EBITDA | $-50M | $-67M | $-172M | · |
Bilans 24
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Cash & Equivalents | $28M | $30M | $65M | $194M | |
| Receivables | $233.0K | $131.0K | $71.0K | $248.0K | |
| Inventory | $722.0K | $679.0K | $2M | $2M | |
| Prepaid Expense | $4M | $5M | $3M | $3M | |
| Other Current Assets | $11M | $1M | $2M | $4M | |
| Current Assets | $45M | $37M | $72M | $203M | |
| PP&E (Net) | $175.0K | $475.0K | $784.0K | $1M | |
| PP&E (Gross) | $2M | $2M | $2M | $2M | |
| Accum. Depreciation | $2M | $2M | $1M | $885.0K | |
| Other Non-current Assets | $0 | $87.0K | $87.0K | $925.0K | |
| Total Assets | $45M | $38M | $74M | $206M | |
| Accounts Payable | $15M | $16M | $14M | $10M | |
| Accrued Liabilities | $4M | $6M | $12M | $19M | |
| Current Liabilities | $54M | $22M | $27M | $33M | |
| Capital Leases | $0 | $65.0K | $440.0K | $786.0K | |
| Total Liabilities | $140M | $131M | $130M | $129M | |
| Long-term Debt | $110M | $103M | · | · | |
| Total Debt | $110M | $103M | $101M | · | |
| Common Stock | $76.0K | $49.0K | $30.0K | $28.0K | |
| Paid-in Capital | $625M | $557M | $534M | $488M | |
| Retained Earnings | $-720M | $-650M | $-591M | $-412M | |
| Stockholders' Equity | $-95M | $-93M | $-57M | $77M | |
| Liabilities + Equity | $45M | $38M | $74M | $206M | |
| Shares Outstanding | 22,328,000 | 3,102,000 | 1,871,000 | 1,759,000 |
Przepływy pieniężne 12
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Stock-based Comp | $3M | $6M | $19M | $17M | |
| Restructuring | $194.0K | $2M | $4M | · | |
| Operating Cash Flow | $-58M | $-72M | $-155M | $-135M | |
| CapEx | $0 | $0 | $20.0K | $139.0K | |
| Investing Cash Flow | $0 | $0 | $-20.0K | $-139.0K | |
| Debt Issued | · | · | · | $99M | |
| Net Debt Issued | $0 | $-2M | · | · | |
| Stock Issued | · | · | $27M | · | |
| Net Stock Activity | · | · | $27M | · | |
| Financing Cash Flow | $57M | $37M | $27M | $96M | |
| Net Change in Cash | $-1M | $-35M | $-129M | $-39M | |
| Free Cash Flow | $-58M | · | $-155M | · |
Rentowność 5
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Operating Margin | -7860.0% | -2967.6% | -12448.0% | · | |
| Net Margin | -10887.4% | -2630.1% | -12974.9% | · | |
| EBITDA Margin | -7860.0% | -2967.6% | -12448.0% | · | |
| ROA | -167.9% | -106.4% | -128.1% | · | |
| ROE | 68.8% | 66.7% | 368.7% | · |
Płynność i wypłacalność 5
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Current Ratio | 0.8 | 1.7 | 2.6 | · | |
| Quick Ratio | 0.5 | 1.3 | 2.4 | · | |
| Debt / Equity | -1.1 | -1.1 | -1.8 | · | |
| LT Debt / Equity | -0.9 | -1.1 | -1.8 | · | |
| Interest Coverage | · | · | -12.9 | · |
Efektywność 3
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | · | |
| Inventory Turnover | 0.2 | 1.6 | 0.6 | · | |
| Receivables Turnover | 3.5 | 22.4 | 8.7 | · |
Stopy Wzrostu 2
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue YoY | -71.7% | 64.2% | 268.0% | · | |
| Revenue CAGR 3Y | 19.6% | · | · | · |
Wycena (TTM) 14
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue TTM | $642.0K | $2M | $1M | $375.0K | |
| Net Income TTM | $-70M | $-60M | $-179M | $-166M | |
| Market Cap | $36M | $19M | $1.41B | · | |
| Enterprise Value | $117M | $91M | $1.45B | · | |
| P/E | -0.3 | -0.3 | -0.5 | -58.1 | |
| P/S | 55.6 | 8.2 | 1023.7 | · | |
| P/B | -0.4 | -0.2 | -25.0 | · | |
| P / Tangible Book | · | · | · | 126.0 | |
| P / Cash Flow | -0.6 | -0.3 | -9.1 | · | |
| P / FCF | -0.6 | · | -9.1 | · | |
| EV / EBITDA | -2.3 | -1.4 | -8.4 | · | |
| EV / FCF | -2.0 | · | -9.3 | · | |
| EV / Revenue | 182.1 | 40.3 | 1049.3 | · | |
| Earnings Yield | -358.1% | -392.9% | -208.3% | -1.7% |
Rachunek zysków i strat 15
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $182.0K | $206.0K | $256.0K | $98.0K | $120.0K | $168.0K | $366.0K | $214.0K | $1M | $582.0K | $376.0K | $341.0K | $457.0K | $206.0K | $238.0K | $137.0K | |
| Cost of Revenue | $22.0K | $283.0K | $32.0K | $11.0K | $107.0K | $14.0K | $831.0K | $1M | $62.0K | $80.0K | $713.0K | $512.0K | $26.0K | $9.0K | $9.0K | $11.0K | |
| R&D Expense | $3M | $3M | $7M | $9M | $10M | $5M | $6M | $5M | $8M | $11M | $10M | $20M | $27M | $28M | $33M | $22M | |
| SG&A Expense | $7M | $7M | $4M | $5M | $6M | $6M | $4M | $8M | $9M | $13M | $10M | $24M | $26M | $24M | $20M | $17M | |
| Operating Expenses | $10M | $10M | $11M | $14M | $16M | $10M | $11M | $16M | $18M | $25M | $20M | $49M | $53M | $51M | $53M | $39M | |
| Operating Income | $-10M | $-10M | $-10M | $-14M | $-16M | $-10M | $-10M | $-15M | $-17M | $-24M | $-20M | $-48M | $-52M | $-51M | $-53M | $-39M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $4M | · | $3M | $3M | $3M | $3M | $4M | |
| Interest Income | $131.0K | $211.0K | $321.0K | $236.0K | $230.0K | $279.0K | $368.0K | $616.0K | $671.0K | $947.0K | $945.0K | $1M | $2M | $2M | $1M | $823.0K | |
| Other Non-op | $-394.0K | $2M | $2M | $-13M | $657.0K | $7M | $3M | $5M | $12M | $32.0K | $108.0K | $-5.0K | $537.0K | $-246.0K | $-480.0K | $62.0K | |
| Net Income | $-15M | $-13M | $-13M | $-31M | $-19M | $-7M | $-11M | $-14M | $-8M | $-27M | $-22M | $-50M | $-54M | $-53M | $-55M | $-42M | |
| EPS (Basic) | $-0.49 | $-0.54 | $0.40 | $-2.18 | $-2.45 | $-1.50 | $-1.17 | $-5.15 | $-3.30 | $-13.89 | $-92.94 | $-1.72 | $-1.83 | $-1.84 | $-1.96 | $-1.49 | |
| EPS (Diluted) | $-0.49 | $-0.54 | $0.40 | $-2.18 | $-2.45 | $-1.50 | $-1.17 | $-5.15 | $-3.30 | $-13.89 | $-92.94 | $-1.72 | $-1.83 | $-1.84 | $-1.96 | $-1.49 | |
| Shares (Basic) | 30,300,000 | 23,571,000 | -14,665,000 | 14,196,000 | 7,843,000 | 4,834,000 | -4,559,000 | 2,649,000 | 2,516,000 | 1,929,000 | -85,250,000 | 29,268,000 | 29,187,000 | 28,616,000 | -55,976,000 | 28,022,000 | |
| Shares (Diluted) | 30,300,000 | 23,571,000 | -14,665,000 | 14,196,000 | 7,843,000 | 4,834,000 | -4,559,000 | 2,649,000 | 2,516,000 | 1,929,000 | -85,250,000 | 29,268,000 | 29,187,000 | 28,616,000 | -28,023,980 | 28,022,000 | |
| EBITDA | $-10M | · | · | $-14M | $-16M | $-10M | · | $-15M | $-17M | $-24M | · | $-48M | $-52M | $-51M | · | $-39M |
Bilans 24
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $13M | $17M | $28M | $36M | $17M | $31M | $30M | $40M | $56M | $74M | $65M | $90M | $128M | $166M | $194M | $232M | |
| Receivables | $82.0K | $216.0K | $233.0K | $0 | $17.0K | · | $131.0K | $3.0K | $812.0K | $378.0K | $71.0K | $735.0K | $431.0K | $283.0K | $248.0K | · | |
| Inventory | $483.0K | $500.0K | $722.0K | $459.0K | $506.0K | $642.0K | $679.0K | $2M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | |
| Prepaid Expense | $3M | $4M | $4M | $6M | $5M | $5M | $5M | $4M | $3M | $2M | $3M | $4M | $4M | $5M | $3M | $6M | |
| Other Current Assets | $11M | $12M | $11M | $934.0K | $995.0K | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $5M | $5M | $4M | $2M | |
| Current Assets | $29M | $34M | $45M | $44M | $25M | $38M | $37M | $48M | $64M | $81M | $72M | $99M | $138M | $177M | $203M | $242M | |
| PP&E (Net) | $99.0K | $117.0K | $175.0K | $249.0K | $324.0K | $399.0K | $475.0K | $552.0K | $629.0K | $706.0K | $784.0K | $862.0K | $941.0K | $1M | $1M | $1M | |
| PP&E (Gross) | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Accum. Depreciation | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $965.0K | $885.0K | $848.0K | |
| Other Non-current Assets | · | · | $0 | $0 | · | $87.0K | $87.0K | $87.0K | $87.0K | $87.0K | $87.0K | $87.0K | $87.0K | $925.0K | $925.0K | $925.0K | |
| Total Assets | $29M | $34M | $45M | $45M | $26M | $39M | $38M | $49M | $65M | $82M | $74M | $100M | $140M | $180M | $206M | $245M | |
| Accounts Payable | $19M | $16M | $15M | $16M | $17M | $15M | $16M | $15M | $13M | $17M | $14M | $11M | $11M | $8M | $10M | $6M | |
| Accrued Liabilities | $4M | $6M | $4M | $4M | $5M | $4M | $6M | $10M | $13M | $14M | $12M | $27M | $19M | $17M | $19M | $14M | |
| Current Liabilities | $137M | $55M | $54M | $38M | $33M | $26M | $22M | $26M | $27M | $31M | $27M | $39M | $35M | $29M | $33M | $23M | |
| Capital Leases | · | · | $0 | $0 | · | · | $65.0K | $161.0K | $256.0K | $350.0K | $440.0K | $529.0K | $617.0K | $703.0K | $786.0K | $868.0K | |
| Total Liabilities | $144M | $140M | $140M | $134M | $133M | $129M | $131M | $135M | $140M | $155M | $130M | $141M | $134M | $127M | $129M | $118M | |
| Long-term Debt | $104M | $100M | $110M | $109M | $109M | $106M | $103M | · | · | · | · | · | · | · | · | · | |
| Total Debt | $104M | · | · | $109M | $109M | $106M | · | $104M | $103M | $102M | · | $99M | $97M | $95M | · | $92M | |
| Common Stock | $31.0K | $27.0K | $76.0K | $73.0K | $60.0K | $59.0K | $49.0K | $42.0K | $40.0K | $34.0K | $30.0K | $29.0K | $29.0K | $29.0K | $28.0K | $28.0K | |
| Paid-in Capital | $632M | $627M | $625M | $619M | $569M | $567M | $557M | $554M | $551M | $545M | $534M | $528M | $524M | $517M | $488M | $484M | |
| Retained Earnings | $-747M | $-733M | $-720M | $-708M | $-677M | $-657M | $-650M | $-639M | $-626M | $-617M | $-591M | $-568M | $-518M | $-464M | $-412M | $-357M | |
| Stockholders' Equity | $-115M | $-106M | $-95M | $-89M | $-108M | $-90M | $-93M | $-86M | $-74M | $-72M | $-57M | $-41M | $6M | $53M | $77M | $127M | |
| Liabilities + Equity | $29M | $34M | $45M | $45M | $26M | $39M | $38M | $49M | $65M | $82M | $74M | $100M | $140M | $180M | $206M | $245M | |
| Shares Outstanding | 31,305,000 | 27,075,000 | 22,328,000 | 19,996,000 | 6,620,000 | 5,468,000 | 3,102,000 | 42,462,000 | 40,383,000 | 33,632,000 | 1,871,000 | 29,273,000 | 29,267,000 | 29,100,000 | 28,147,000 | 28,023,000 |
Przepływy pieniężne 10
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $358.0K | $435.0K | $450.0K | $581.0K | $2M | $180.0K | $-199.0K | $2M | $1M | $3M | $4M | $4M | $6M | $5M | $5M | $4M | |
| Restructuring | · | $0 | $0 | $194.0K | $0 | $0 | $32.0K | $2M | $856.0K | · | $0 | $4M | · | · | · | · | |
| Operating Cash Flow | $-6M | $-12M | $-14M | $-19M | $-13M | $-12M | $-15M | $-16M | $-23M | $-18M | $-27M | $-38M | $-38M | $-52M | $-39M | $-31M | |
| CapEx | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | · | $0 | $0 | · | · | $0 | $0 | |
| Investing Cash Flow | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | · | $0 | $0 | · | · | $0 | $0 | |
| Debt Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $30M | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $25M | · | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | · | · | $25M | · | · | |
| Financing Cash Flow | $3M | $232.0K | $6M | $38M | $137.0K | $13M | $4M | $454.0K | $5M | $27M | $2M | $0 | $250.0K | $24M | $50.0K | $30M | |
| Net Change in Cash | $-3M | $-12M | $-9M | $19M | $-12M | $1M | $-11M | $-16M | $-18M | $9M | $-25M | $-38M | $-38M | $-28M | $-39M | $-1M |
Rentowność 5
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -5600.6% | · | · | -14518.4% | -13210.0% | -6011.3% | · | -7146.3% | -1566.7% | -4151.7% | · | -14163.3% | -11469.1% | -24853.4% | · | -28459.8% | |
| Net Margin | -8084.1% | · | · | -31541.8% | -15989.2% | -4317.9% | · | -6378.5% | -751.7% | -4603.3% | · | -14805.3% | -11710.1% | -25629.1% | · | -30514.6% | |
| EBITDA Margin | -5600.6% | · | · | -14518.4% | -13210.0% | -6011.3% | · | -7146.3% | -1566.7% | -4151.7% | · | -14163.3% | -11469.1% | -24853.4% | · | -28459.8% | |
| ROA | -53.9% | · | · | -66.0% | -42.1% | -12.0% | · | -18.3% | -8.1% | -20.4% | · | -29.2% | -27.6% | -27.0% | · | -16.5% | |
| ROE | 13.2% | · | · | 35.4% | 21.1% | 8.9% | · | 21.6% | 24.2% | 276.8% | · | -116.9% | -62.9% | -42.8% | · | -22.4% |
Płynność i wypłacalność 5
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.2 | · | · | 1.2 | 0.8 | 1.5 | · | 1.9 | 2.4 | 2.6 | · | 2.5 | 4.0 | 6.2 | · | 10.3 | |
| Quick Ratio | 0.1 | · | · | 1.0 | 0.5 | 1.2 | · | 1.6 | 2.1 | 2.4 | · | 2.3 | 3.7 | 5.8 | · | 9.9 | |
| Debt / Equity | -0.9 | · | · | -1.2 | -1.0 | -1.2 | · | -1.2 | -1.4 | -1.4 | · | -2.4 | 16.5 | 1.8 | · | 0.7 | |
| LT Debt / Equity | 0.0 | · | · | -1.0 | -0.9 | -1.1 | · | -1.2 | -1.4 | -1.4 | · | -2.4 | 16.5 | 1.8 | · | 0.7 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -6.7 | · | -14.9 | -16.1 | -15.2 | · | -10.5 |
Efektywność 3
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Inventory Turnover | 0.0 | · | · | 0.0 | 0.1 | 0.0 | · | 0.7 | 0.0 | 0.0 | · | 0.3 | 0.0 | 0.0 | · | 0.0 | |
| Receivables Turnover | 3.7 | · | · | 65.3 | 0.3 | · | · | 0.6 | 1.8 | 1.8 | · | 0.9 | 2.1 | 1.5 | · | · |
Wycena (TTM) 12
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $606.0K | $592.0K | · | $600.0K | $2M | $2M | · | $2M | $2M | $2M | · | $1M | · | · | · | · | |
| Net Income TTM | $-78M | $-70M | · | $-71M | $-48M | $-56M | · | $-99M | $-139M | $-184M | · | $-199M | $-186M | $-164M | · | $-138M | |
| Market Cap | $44M | · | · | $51M | $12M | $11M | · | $414M | $827M | $1.52B | · | $1.18B | $3.12B | $8.69B | · | $5.30B | |
| Enterprise Value | $136M | · | · | $124M | $103M | $86M | · | $478M | $874M | $1.54B | · | $1.19B | $3.09B | $8.62B | · | $5.16B | |
| P/E | -0.2 | -0.2 | · | -0.2 | -0.1 | -0.1 | · | -0.4 | -1.0 | -2.3 | · | -5.9 | -16.4 | -51.5 | · | -38.4 | |
| P/S | 72.8 | · | · | 85.3 | 7.5 | 5.4 | · | 184.9 | 332.9 | 956.8 | · | 1038.5 | · | · | · | · | |
| P/B | -0.4 | · | · | -0.6 | -0.1 | -0.1 | · | -4.8 | -11.1 | -21.0 | · | -29.2 | 531.8 | 163.9 | · | 41.7 | |
| P / Tangible Book | · | · | · | · | · | · | · | · | · | · | · | · | 531.8 | 163.9 | · | 41.7 | |
| P / Cash Flow | · | · | · | · | · | -0.9 | · | · | · | -85.7 | · | · | · | -166.0 | · | · | |
| EV / EBITDA | -13.3 | · | · | -8.7 | -6.5 | -8.5 | · | -31.3 | -50.5 | -63.9 | · | -24.7 | -58.9 | -168.3 | · | -132.3 | |
| EV / Revenue | 224.0 | · | · | 206.9 | 64.3 | 41.4 | · | 213.5 | 351.8 | 974.1 | · | 1046.5 | · | · | · | · | |
| Earnings Yield | -401.4% | -497.8% | · | -440.6% | -685.1% | -1174.4% | · | -246.5% | -101.3% | -42.7% | · | -17.0% | -6.1% | -1.9% | · | -2.6% |
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
Rachunek zysków i strat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Przychody | $642.0K | $2M | $1M | $375.0K | — |
| Marża Operacyjna % | -7860.0% | -2967.6% | -12448.0% | — | — |
| Zysk netto | $-70M | $-60M | $-179M | $-166M | $-107M |
| Rozwodniony EPS | $-5.73 | $-23.51 | $-98.33 | $-5.92 | $-4.05 |
Bilans
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Dług / Kapitał Własny | -1.1 | -1.1 | -1.8 | — | — |
| Wskaźnik bieżący | 0.8 | 1.7 | 2.6 | — | 14.2 |
| Wskaźnik Szybkości | 0.5 | 1.3 | 2.4 | — | 14.0 |
Przepływy pieniężne
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $-58M | — | $-155M | — | $-83M |
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
📊
Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Właściciele instytucjonalni (13F) 50 emitentów · $8.5M łącznie · Na dzień 30 czerwca 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 14 (+9 vs poprzedni kw.) | 3 (-5 vs poprzedni kw.) | 7 (-2 vs poprzedni kw.) | 9 (+3 vs poprzedni kw.) | +725K |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| MILLENNIUM MANAGEMENT LLC | $2 981 741 | 2 114 710 | 35,24% | Akcje |
| OAKTREE CAPITAL MANAGEMENT LP | $1 946 150 | 1 380 248 | 23,00% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $1 296 558 | 919 545 | 15,32% | Akcje |
| Oaktree Fund Advisors, LLC | $346 274 | 245 585 | 4,09% | Akcje |
| VANGUARD GROUP INC | $331 742 | 207 339 | 3,92% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $284 141 | 201 279 | 3,36% | Akcje |
| CITADEL ADVISORS LLC | $210 400 | 149 220 | 2,49% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $193 081 | 136 937 | 2,28% | Akcje |
| STATE STREET CORP | $129 886 | 92 118 | 1,54% | Akcje |
| FMR LLC | $127 323 | 90 300 | 1,50% | Akcje |
| &PARTNERS | $117 859 | 83 588 | 1,39% | Akcje |
| JONES FINANCIAL COMPANIES LLLP | $82 712 | 63 139 | 0,98% | Akcje |
| NORTHERN TRUST CORP | $79 407 | 56 317 | 0,94% | Akcje |
| HighTower Advisors, LLC | $57 810 | 41 000 | 0,68% | Akcje |
| Quadrature Capital Ltd | $53 634 | 38 038 | 0,63% | Akcje |
| Headlands Technologies LLC | $36 034 | 25 556 | 0,43% | Akcje |
| StoneX Group Inc. | $29 164 | 20 684 | 0,34% | Akcje |
| Beacon Pointe Advisors, LLC | $25 296 | 18 877 | 0,30% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $24 252 | 17 200 | 0,29% | Akcje |
| Portfolio Strategies, Inc. | $23 732 | 16 831 | 0,28% | Akcje |
| OSAIC HOLDINGS, INC. | $22 860 | 16 214 | 0,27% | Akcje |
| TWO SIGMA SECURITIES, LLC | $15 222 | 10 796 | 0,18% | Akcje |
| DIVERSIFY WEALTH MANAGEMENT, LLC | $13 005 | 15 000 | 0,15% | Akcje |
| Diversify Advisory Services, LLC | $13 005 | 15 000 | 0,15% | Akcje |
| BlackRock, Inc. | $8 384 | 5 946 | 0,10% | Akcje |
| CITIGROUP INC | $4 227 | 2 998 | 0,05% | Akcje |
| BARCLAYS PLC | $2 013 | 1 428 | 0,02% | Akcje |
| NewEdge Advisors, LLC | $1 877 | 1 331 | 0,02% | Akcje |
| Vanguard Global Advisers, LLC | $695 | 493 | 0,01% | Akcje |
| Silver Grove Financial Group, Inc. | $468 | 331 | 0,01% | Akcje |
| AllSquare Wealth Management LLC | $448 | 175 | 0,01% | Akcje |
| Tower Research Capital LLC (TRC) | $320 | 227 | 0,00% | Akcje |
| MORGAN STANLEY | $313 | 222 | 0,00% | Akcje |
| UBS Group AG | $214 | 152 | 0,00% | Akcje |
| Parkside Financial Bank & Trust | $151 | 112 | 0,00% | Akcje |
| Washington Trust Advisors, Inc. | $116 | 82 | 0,00% | Akcje |
| EverSource Wealth Advisors, LLC | $85 | 60 | 0,00% | Akcje |
| JPMORGAN CHASE & CO | $63 | 45 | 0,00% | Akcje |
| MERCER GLOBAL ADVISORS INC /ADV | $45 | 32 | 0,00% | Akcje |
| Farther Finance Advisors, LLC | $35 | 25 | 0,00% | Akcje |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | $30 | 21 | 0,00% | Akcje |
| WELLS FARGO & COMPANY/MN | $25 | 18 | 0,00% | Akcje |
| Virtu Financial LLC | $23 | 15 967 | 0,00% | Akcje |
| SBI Securities Co., Ltd. | $18 | 13 | 0,00% | Akcje |
| IFP Advisors, Inc | $18 | 13 | 0,00% | Akcje |
| BNP PARIBAS FINANCIAL MARKETS | $17 | 12 | 0,00% | Akcje |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $3 | 2 | 0,00% | Akcje |
| US BANCORP \DE\ | $1 | 1 | 0,00% | Akcje |
| Triumph Capital Management | $1 | 1 | 0,00% | Akcje |
| GROUP ONE TRADING LLC | $1 | 1 | 0,00% | Akcje |
Insiderzy spółki 19 insiderów · 6 dyrektorzy generalni · 9 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Vimal Mehta | CEO and President | 15 czerwca 2026 M | 69 817 | 0 | 1 | $-21 167 |
| Richard I Steinhart | Chief Financial Officer | 15 czerwca 2026 M | 26 335 | 0 | 1 | $-7 393 |
| Javier Rodriguez | Chief Legal Officer, Senior Vice President and Corporate Secretary | 15 czerwca 2026 M | 26 838 | 0 | 1 | $-7 085 |
| Frank Yocca | Chief Scientific Officer | 15 czerwca 2026 M | 26 210 | 0 | 1 | $-7 393 |
| William P Kane Jr | Chief Commercial Officer | 16 sierpnia 2021 A | — | 0 | 0 | $0 |
| Reina Benabou | Senior Vice President Clinical Research Neuroscience and Chief Development Officer | 22 czerwca 2020 A | — | 0 | 0 | $0 |
| June Bray | Dyrektor | 9 stycznia 2026 A | — | 0 | 0 | $0 |
| Sandeep Laumas | Dyrektor | 9 stycznia 2026 A | — | 0 | 0 | $0 |
| David J. Mack | Dyrektor | 9 stycznia 2026 A | 20 317 | 0 | 0 | $0 |
| Michal Votruba | Dyrektor | 9 stycznia 2026 A | — | 0 | 0 | $0 |
| Rajiv Patni | Dyrektor | 9 stycznia 2026 A | — | 0 | 0 | $0 |
| Peter Mueller | Dyrektor | 9 stycznia 2026 A | 90 000 | 0 | 0 | $0 |
| MILLER MICHAEL PATRICK | Dyrektor | 9 stycznia 2026 A | — | 0 | 0 | $0 |
| Krishnan Nandabalan | Dyrektor | 6 kwietnia 2023 M | 0 | 0 | 0 | $0 |
| Susan E. Atkins | — | 12 sierpnia 2026 A | — | 0 | 0 | $0 |
| Matthew T. Wiley | — | 22 lipca 2024 A | 19 011 | 0 | 0 | $0 |
| Vincent O'Neill | — | 22 lipca 2024 A | 19 957 | 0 | 0 | $0 |
| BioXcel Holdings, Inc. | — | 25 czerwca 2021 S | 8 546 750 | 0 | 0 | $0 |
| BioXcel Corp | — | 25 czerwca 2021 S | 8 546 750 | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Aktywiści i właściciele 5%+ 2 akcje
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| BioXcel LLC, BioXcel Holdings, Inc., Vimal Mehta ×2 zgłoszenia | 6 czerwca 2024 | — | Pierwotne zgłoszenie | — | SEC |
| DNCA FINANCE S.C.S ×4 zgłoszenia | 6 marca 2020 | — | Pierwotne zgłoszenie | Inwestycja pasywna | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Posiadanie ETF-ów Posiadane przez 3 fundusze ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.